About this Journal Submit a Manuscript Table of Contents
Case Reports in Medicine
Volume 2012 (2012), Article ID 726841, 4 pages
http://dx.doi.org/10.1155/2012/726841
Case Report

Metachronous Rectum Metastases from Gastric Adenocarcinoma: A Case Report

1Division of Medical Oncology, Department of Internal Medicine, Cerrahpaşa Medical Faculty, İstanbul University, 34098 İstanbul, Turkey
2Department of Radiation Oncology, İstanbul Education and Research Hospital, İstanbul, Turkey
3Department of Pathology, İstanbul Education and Research Hospital, İstanbul, Turkey

Received 2 August 2012; Revised 16 October 2012; Accepted 30 October 2012

Academic Editor: Peter J. K. Kuppen

Copyright © 2012 Deniz Tural et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. J. Feczko, D. D. Collins, and D. G. Mezwa, “Metastatic disease involving the gastrointestinal tract,” Radiologic Clinics of North America, vol. 31, no. 6, pp. 1359–1373, 1993. View at Scopus
  2. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun, “Cancer statistics, 2007,” CA: A Cancer Journal for Clinicians, vol. 57, no. 1, pp. 43–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. World Health Organization, Cancer Surveillance Database, http://www-dep.iarc.fr/.
  4. R. E. Hermann, “Newer concepts in the treatment of cancer of the stomach,” Surgery, vol. 113, no. 4, pp. 361–364, 1993. View at Scopus
  5. M. D. Abeloff, J. O. Armitage, J. E. Niederhuber, M. B. Kastan, and W. G. McKenna, Abeloff's Clinical Oncology, 4th edition, 2008.
  6. U. Pacea, G. Continoa, A. Chiappaa et al., “Metachronous colon metastases from gastric adenocarcinoma: a case report,” Case Reports in Oncology, vol. 2, no. 2, pp. 92–96, 2009. View at Publisher · View at Google Scholar
  7. S. Uzunoğlu, İ. Çiçin, H. Karagöl, Ö. Tanrıverdi, H. Gençhellaç, and U. Usta, “Rektuma Linitis Plastika Şeklinde Metastaz Yapan ve Primer Rektum Kanseri Gibi Görünen Mide Adenokarsinomu: Olgu Sunumu,” Trakya Üniversitesi Tıp Fakültesi Dergisi, vol. 25, pp. 160–163, 2008.
  8. S. W. Lim, J. W. Huh, Y. J. Kim, and H. R. Kim, “Laparoscopic low anterior resection forhematogenous rectal metastasis from gastric adenocarcinoma: a case report,” World Journal of Surgical Oncology, vol. 9, article 148, 2011. View at Publisher · View at Google Scholar
  9. O. Hosokawa, S. Tsuda, E. Kidani et al., “Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy,” Endoscopy, vol. 30, no. 8, pp. 669–674, 1998. View at Scopus
  10. S. Willis, S. Truong, S. Gribnitz, J. Fass, and V. Schumpelick, “Endoscopic ultrasonography in the preoperative staging of gastric cancer: accuracy and impact on surgical therapy,” Surgical Endoscopy, vol. 14, no. 10, pp. 951–954, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Y. Wang, J. S. Hsieh, Y. S. Huang, C. J. Huang, M. F. Hou, and T. J. Huang, “Endoscopic ultrasonography for preoperative locoregional staging and assessment of resectability in gastric cancer,” Clinical Imaging, vol. 22, no. 5, pp. 355–359, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Kinkel, Y. Lu, M. Both, R. S. Warren, and R. F. Thoeni, “Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis,” Radiology, vol. 224, no. 3, pp. 748–756, 2002. View at Scopus
  13. T. Tot, “Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors,” Cancer, vol. 85, no. 1, pp. 171–177, 1999.
  14. H. Kawamura, Y. Kondo, S. Osawa et al., “A clinicopathologic study of mucinous adenocarcinoma of the stomach,” Gastric Cancer, vol. 4, no. 2, pp. 83–86, 2001. View at Scopus
  15. C. A. Hudis, “Trastuzumab—mechanism of action and use in clinical practice,” The New England Journal of Medicine, vol. 357, no. 1, pp. 39–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Takehana, K. Kunitomo, K. Kono et al., “Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay,” International Journal of Cancer, vol. 98, no. 6, pp. 833–837, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. C. H. Köhne, J. A. Wils, and H. J. Wilke, “Developments in the treatment of gastric cancer in Europe,” Oncology, vol. 14, no. 12, pp. 22–25, 2000. View at Scopus
  18. E. van Cutsem, V. M. Moiseyenko, S. Tjulandin et al., “Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V25 study group,” Journal of Clinical Oncology, vol. 24, no. 31, pp. 4991–4997, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. D. H. Ilson, “Docetaxel, cisplatin, and fluorouracil in gastric cancer: does the punishment fit the crime?” Journal of Clinical Oncology, vol. 25, no. 22, pp. 3188–3190, 2007. View at Publisher · View at Google Scholar · View at Scopus